Iowa SF2322 mandates a cap on cost-sharing for prescription insulin drugs at $35 per 31-day supply.
Iowa SF2322 requires policies, contracts, or plans providing coverage for prescription drugs to limit the cost-sharing for prescription insulin drugs to no more than $35 for a 31-day supply. This applies to individual or group accident and sickness insurance, hospital or medical service contracts, health maintenance organization contracts, and public employee plans. The bill excludes accident-only, specified disease, short-term hospital or medical, hospital confinement indemnity, credit, dental, vision, Medicare supplement, and long-term diabetes insurance.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.